CORD-19:68a7101a90454172c91785d8c352f776a82df5d4 / 19016-19136 JSONTXT

{"project":"CORD-19-Sentences","denotations":[{"id":"TextSentencer_T122","span":{"begin":0,"end":120},"obj":"Sentence"}],"namespaces":[{"prefix":"_base","uri":"http://pubannotation.org/ontology/tao.owl#"}],"text":"Interferon beta (IFNb) treatment is beneficial for a majority of Relapsing-Remitting Multiple Sclerosis (RRMS) patients."}

{"project":"CORD-19_Custom_license_subset","denotations":[{"id":"T122","span":{"begin":0,"end":120},"obj":"Sentence"}],"text":"Interferon beta (IFNb) treatment is beneficial for a majority of Relapsing-Remitting Multiple Sclerosis (RRMS) patients."}

{"project":"CORD-19-PD-MONDO","denotations":[{"id":"T25207","span":{"begin":65,"end":103},"obj":"Disease"},{"id":"T85966","span":{"begin":105,"end":109},"obj":"Disease"},{"id":"T31819","span":{"begin":65,"end":103},"obj":"Disease"},{"id":"T24804","span":{"begin":105,"end":109},"obj":"Disease"}],"attributes":[{"id":"A50569","pred":"mondo_id","subj":"T25207","obj":"http://purl.obolibrary.org/obo/MONDO_0005314"},{"id":"A85446","pred":"mondo_id","subj":"T85966","obj":"http://purl.obolibrary.org/obo/MONDO_0005314"},{"id":"A74765","pred":"mondo_id","subj":"T31819","obj":"http://purl.obolibrary.org/obo/MONDO_0005314"},{"id":"A35459","pred":"mondo_id","subj":"T24804","obj":"http://purl.obolibrary.org/obo/MONDO_0005314"}],"text":"Interferon beta (IFNb) treatment is beneficial for a majority of Relapsing-Remitting Multiple Sclerosis (RRMS) patients."}